Artequick, a combination of artemisinin and piperaquine, is an ideal drug for the treatment of malaria and especially for the treatment of resistant P.falciparum malaria.
Direction for Use
For adults, 2 tablets at 0 hr and 24 hrs, with 4 tablets as total dose. Dosages for different age groups are as follows.
Artemisinin is toxic to the early embryo in animal studies but there is no data available on use in pregnant women during the first trimester. Clinical data after the first trimester show no adverse effects.
Nausea and vomiting are found occasionally when taking drug with empty stomach, but the occurrence rate of them is less than 3%